2020 Detroit Multiple Sclerosis Conference

Due to ongoing health concerns regarding the spread of coronavirus (COVID-19), the 2020 Detroit MS Conference scheduled to be held Friday, March 20 at Henry Ford Hospital will be postponed. The health and safety of our patients, team members and guests is our top priority. We are continuing to monitor the situation and will announce the rescheduled date as soon as possible. Refunds will be issued to all registered attendees as appropriate. For questions, contact the Continuing Medical Education office at (313) 916-3905.

The Henry Ford Neuroscience Institute presents the 2020 Detroit Multiple Sclerosis Conference. This all-day event brings together some of the finest minds in medicine to present the latest research and data for the management and treatment of multiple sclerosis.

National Multiple Sclerosis Society LogoThe Consortium of Multiple Sclerosis Centers logoThe Henry Ford Multiple Sclerosis Program was first in Michigan to be designated as a Center for Comprehensive Multiple Sclerosis Care and advanced research by the National Multiple Sclerosis Society. With more than 1,000 unique patient encounters annually, and 2,300 outpatient visits per year, Henry Ford Hospital is home to one of the busiest programs in the U.S. Our program is led by renowned neurologists long known for expertise in the diagnosis and management of multiple sclerosis.

Featured keynotes

Stem Cell Therapy in MS

Presenter: Mark Freedman, M.D., HBSc, MSc, CSPQ, FAAN, FRCPC
Senior Scientist, Neuroscience Program, Ottawa Hospital Research Institute; Professor of Medicine, Neurology, University of Ottawa; and Director, Multiple Sclerosis Research Unit, Neurology Ottawa Hospital-General Campus.

Induction Therapy vs. When to Escalate Therapy

Adil Javed, M.D., PhD
Associate Professor of Neurology, Department of Neurology, University of Chicago.

B-Cell Story in Multiple Sclerosis

Robert Lisak, M.D.
Parker Webber Chair in Neurology and Professor of Neurology and Professor of Biochemistry, Microbiology and Immunology, Wayne State University School of Medicine.

Biomarkers in MS: Can We Use Them in the Future?

Yang Mao-Draayer, M.D., PhD
Clinical Professor of Neurology, Multiple Sclerosis Center/ Holtom-Garrett Neuroimmunology Program, Michigan Medicine.

View Full Agenda and Speaker Lineup